AnnJi Pharmaceutical News

Dedicated to New Drug Development in Dermatology & Neurology

AnnJi’s Company Presentation is Now Live at BIOAsia-Taiwan 2022

AnnJi is a clinical-stage pharmaceutical company focusing on developing innovative therapeutics to improve the quality of life of patients with dermatological and neurological diseases.

Watch online (below or BIOAsia-Taiwan 2022 if you have registered for the conference), for the latest update of our clinical projects: AJ101 for dermatology and AJ201 for rare neurological diseases. We are seeking product development partners for the global market.  Please contact us at if you are interested in meeting with us.

Scroll to Top